Physician profile
Kara Mann
NPI 1578936118
$1,783.85
in general payments reported to CMS, 2019-2025
15 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $190 · 2022: $422 · 2023: $425 · 2024: $439 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,170.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $408.19 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $281.81 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Lilly USA, LLC | $194.53 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $194.16 | 2021-2025 | |
| Abbvie INC. | $167.68 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $95.30 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Merck Sharp & Dohme LLC | $90.62 | 2021-2023 | Belsomra, M-M-R II, Gardasil 9 |
| Astellas Pharma US INC | $81.13 | 2023-2024 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $61.11 | 2022-2025 | Shingrix |
| Kowa Pharmaceuticals America, INC. | $50.67 | 2021-2023 | Livalo |
| Otsuka America Pharmaceutical, INC. | $49.14 | 2025 | Rexulti |
| Abbott Laboratories | $35.90 | 2024 | Freestyle Libre 3 |
| Biohaven Pharmaceuticals, INC. | $29.45 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.42 | 2022 | |
| Phathom Pharmaceuticals, INC. | $18.74 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.